NAII:NASDAQNatural Alternatives International, Inc. Analysis
Data as of 2026-05-22 - not real-time
$2.55
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its short‑term moving averages and the 200‑day trend line, with a bearish MACD histogram and an RSI that has slipped into the lower half of its range, indicating lingering oversold pressure. Volume has been on a downtrend and 30‑day price swings are elevated, while beta remains below one, suggesting the price moves more modestly than the market but with pronounced volatility.
Fundamental outlook: Revenue growth is flat and margins are deeply negative, with operating cash flow also in the red. The balance sheet is strained by a debt load that dwarfs cash on hand, and free cash flow is minimal. Valuation metrics such as price‑to‑book and price‑to‑sales are exceptionally low, reflecting a market that is heavily discounting the company’s earnings prospects. The firm operates in the consumer defensive, packaged‑foods segment, but faces heightened regulatory scrutiny in the supplement space and carries limited liquidity given its small market cap and decreasing trading activity.
Fundamental outlook: Revenue growth is flat and margins are deeply negative, with operating cash flow also in the red. The balance sheet is strained by a debt load that dwarfs cash on hand, and free cash flow is minimal. Valuation metrics such as price‑to‑book and price‑to‑sales are exceptionally low, reflecting a market that is heavily discounting the company’s earnings prospects. The firm operates in the consumer defensive, packaged‑foods segment, but faces heightened regulatory scrutiny in the supplement space and carries limited liquidity given its small market cap and decreasing trading activity.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and price below key support levels
- Decreasing volume and high recent volatility
- Weak cash generation and high debt burden
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Extremely low valuation ratios offering a margin of safety
- Potential upside if contract‑manufacturing contracts improve
- Continued earnings and cash‑flow challenges
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Structural exposure to consumer‑defensive demand for supplements
- Regulatory headwinds that could limit growth
- Undervalued balance sheet metrics may attract value‑oriented investors
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin-9.06%
ROE-16.75%
ROA-1.70%
Debt/Equity92.04
P/B Ratio0.2
Op. Cash Flow$-1015000
Free Cash Flow$108.5K
Technical Analysis
TrendBearish
RSI38.8
Support$2.42
Resistance$2.83
MA 20$2.66
MA 50$2.69
MA 200$3.15
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.80
Volatility30.29%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.